Health insurers are marking up the prices of drugs that have gone generic, often charging many multiples of what low-cost pharmacies charge for comparable medicines to treat cancer, multiple sclerosis and other diseases.

Health insurers are marking up the prices of drugs that have gone generic, often charging many multiples of what low-cost pharmacies charge for comparable medicines to treat cancer, multiple sclerosis and other diseases.